Sino Biopharmaceutical Limited SMZ1.F Stock
Sino Biopharmaceutical Limited Price Chart
Sino Biopharmaceutical Limited SMZ1.F Financial and Trading Overview
Sino Biopharmaceutical Limited stock price | 0.35 EUR |
Previous Close | 0.45 EUR |
Open | 0.45 EUR |
Bid | 0.45 EUR x N/A |
Ask | 0.46 EUR x N/A |
Day's Range | 0.45 - 0.45 EUR |
52 Week Range | 0.44 - 0.67 EUR |
Volume | 1K EUR |
Avg. Volume | 526 EUR |
Market Cap | 8.5B EUR |
Beta (5Y Monthly) | 0.623754 |
PE Ratio (TTM) | 22.6 |
EPS (TTM) | 0.01 EUR |
Forward Dividend & Yield | 0.01 (3.33%) |
Ex-Dividend Date | June 20, 2023 |
1y Target Est | N/A |
SMZ1.F Valuation Measures
Enterprise Value | 13.7B EUR |
Trailing P/E | 22.6 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.29540086 |
Price/Book (mrq) | 0.28057107 |
Enterprise Value/Revenue | 0.476 |
Enterprise Value/EBITDA | 2.03 |
Trading Information
Sino Biopharmaceutical Limited Stock Price History
Beta (5Y Monthly) | 0.623754 |
52-Week Change | -12.34% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.67 EUR |
52 Week Low | 0.44 EUR |
50-Day Moving Average | 0.48 EUR |
200-Day Moving Average | 0.51 EUR |
SMZ1.F Share Statistics
Avg. Volume (3 month) | 526 EUR |
Avg. Daily Volume (10-Days) | 1.16K EUR |
Shares Outstanding | 18.81B |
Float | 9.46B |
Short Ratio | N/A |
% Held by Insiders | 47.91% |
% Held by Institutions | 14.71% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.106 |
Trailing Annual Dividend Yield | 23.45% |
5 Year Average Dividend Yield | 106.00% |
Payout Ratio | 0.71669996 |
Last Split Factor | 3:2 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 8.83% |
Operating Margin (ttm) | 20.43% |
Gross Margin | 79.86% |
EBITDA Margin | 23.45% |
Management Effectiveness
Return on Assets (ttm) | 5.89% |
Return on Equity (ttm) | 13.22% |
Income Statement
Revenue (ttm) | 28.78B EUR |
Revenue Per Share (ttm) | 1.55 EUR |
Quarterly Revenue Growth (yoy) | 8.59% |
Gross Profit (ttm) | N/A |
EBITDA | 6.75B EUR |
Net Income Avi to Common (ttm) | 2.54B EUR |
Diluted EPS (ttm) | 0.02 |
Quarterly Earnings Growth (yoy) | -89.79% |
Balance Sheet
Total Cash (mrq) | 16.92B EUR |
Total Cash Per Share (mrq) | 0.92 EUR |
Total Debt (mrq) | 14.12B EUR |
Total Debt/Equity (mrq) | 37.21 EUR |
Current Ratio (mrq) | 1.287 |
Book Value Per Share (mrq) | 1.611 |
Cash Flow Statement
Operating Cash Flow (ttm) | 6.27B EUR |
Levered Free Cash Flow (ttm) | 3.29B EUR |
Profile of Sino Biopharmaceutical Limited
Country | Germany |
State | N/A |
City | Wan Chai |
Address | Unit 09, Office Tower |
ZIP | N/A |
Phone | 852 2802 9886 |
Website | https://www.sinobiopharm.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 26272 |
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
Q&A For Sino Biopharmaceutical Limited Stock
What is a current SMZ1.F stock price?
Sino Biopharmaceutical Limited SMZ1.F stock price today per share is 0.35 EUR.
How to purchase Sino Biopharmaceutical Limited stock?
You can buy SMZ1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sino Biopharmaceutical Limited?
The stock symbol or ticker of Sino Biopharmaceutical Limited is SMZ1.F.
Which industry does the Sino Biopharmaceutical Limited company belong to?
The Sino Biopharmaceutical Limited industry is Biotechnology.
How many shares does Sino Biopharmaceutical Limited have in circulation?
The max supply of Sino Biopharmaceutical Limited shares is 19.01B.
What is Sino Biopharmaceutical Limited Price to Earnings Ratio (PE Ratio)?
Sino Biopharmaceutical Limited PE Ratio is 35.29000000 now.
What was Sino Biopharmaceutical Limited earnings per share over the trailing 12 months (TTM)?
Sino Biopharmaceutical Limited EPS is 0.01 EUR over the trailing 12 months.
Which sector does the Sino Biopharmaceutical Limited company belong to?
The Sino Biopharmaceutical Limited sector is Healthcare.